The cannabis sector is heating up for a big start in Brazil. Deputy Paulo Teixeira (PT-SP) handed over the proposed law 399/2015, which legalizes the cultivation of cannabis in Brazil for medical and industrial use, to the president of the Chamber of Deputies. The proposal foresees an increase in plant-based medicine because it reduces the cost of imported input, lowering the price of cannabis drugs. "In pharmacies, there are two Cannabis-based medicines registered by Anvisa [Health Surveillance Agency], Sativex, produced by the English company GW Pharma, and Cannabidiol, by Brazilian Prati-Donaduzzi," says Teixeira. On average, each costs R $ 2,500. Prati's cannabidiol comes from Canada. (See also: Brazilian plan for legal cultivation of industrial hemp, MMJ moving ahead as nation battles pandemic)